Forbion Capital Overview
Forbion is a leading global venture capital firm with deep expertise in Europe, investing in innovative biotech companies and sustainable solutions that improve the health of people and the planet. Managing approximately €5 billion across multiple fund strategies, Forbion covers all stages of biopharmaceutical drug development and leverages its biotech expertise to address planetary health challenges through its BioEconomy fund strategy.
Is Forbion Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Forbion Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Forbion Capital
Investment focus
Product type
- Materials
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Investment role
Lead and follow
Stages
Series B or later
First ticket size
€70,000,000 - €70,000,000
Contact information
Associate
Alice Vickers
Principal
Antoine Boulanger
Principal
Audrey Cacaly
Operating Partner
Carlo Incerti
How to approach funds like Forbion Capital
When approaching Forbion, founders should highlight robust clinical or preclinical data, a clear path to regulatory milestones, and a differentiated scientific approach. Demonstrating a strong, experienced management team with a track record in biotech or pharma is crucial. Forbion values startups with scalable platforms or assets that can address significant unmet medical needs or offer transformative solutions in planetary health. Articulate how your company’s vision aligns with long-term value creation and global impact, as Forbion is known for its hands-on, partnership-driven investment style.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
